English	French	Notes	Complete/Exclude
    ABDOMINAL INFECTION..............: NA, no treatment			
    ABSCESS..........................: NA, no treatment			
    ADMISSION FOR NEUTROPENIA........: NA, no treatment			
    ANASTOMOTIC DEHISCENCE...........: NA, no treatment			
    BLEEDING/HEMATOMA................: NA, no treatment			
    DEHYDRATION......................: NA, no treatment			
    DIARRHEA.........................: NA, no treatment			
    EARLY BOWEL OBSTRUCTION..........: NA, no treatment			
    PERINEAL INFECTION...............: NA, no treatment			
    PNEUMONIA........................: NA, no treatment			
    PROCTITIS........................: NA, no treatment			
    PULMONARY EMBOLISM...............: NA, no treatment			
    RADIATION ENTERITIS..............: NA, no treatment			
    STOMA COMPLICATION...............: NA, no treatment			
    URINARY TRACT INFECTION..........: NA, no treatment			
  POSTOPERATIVE DEATH W/I 30 DAYS: NA, no surgery			
763  ADDITIONAL SURGICAL PROCEDURES..			
764  LAPAROSCOPY USED DURING SURGERY.			
765  METHOD OF ANASTOMOSIS...........			
766  DIST OF ANASTOMOSIS FROM DENTATE			
59  RESIDUAL PRIMARY TUMOR..........			
769    PATHOLOGICAL STATUS...........			
770    ABDOMINAL INFECTION...........			
772    ADMISSION FOR NEUTROPENIA.....			
773    ANASTOMOTIC DEHISCENCE........			
776    EARLY BOWEL OBSTRUCTION.......			
777    PERINEAL INFECTION............			
780    PULMONARY EMBOLISM............			
781    RADIATION ENTERITIS...........			
782    STOMA COMPLICATION............			
783    URINARY TRACT INFECTION.......			
441  POSTOPERATIVE DEATH W/I 30 DAYS.			
  DATE RADIATION STARTED..........: 			
  DATE RADIATION THERAPY ENDED....: 00/00/0000			
  ENDOCAVITARY RADIATION..........: None			
  INTRA-OPERATIVE RAD THERAPY.....: No			
  PRIMARY TUMOR RAD DOSE W BOOST..: No radiation therapy			
  NUMBER OF RADIATION TREATMENTS..: None			
  DATE RADIATION THERAPY ENDED....: 99/99/9999			
  ENDOCAVITARY RADIATION..........: Unknown			
  INTRA-OPERATIVE RAD THERAPY.....: Unknown			
  PRIMARY TUMOR RAD DOSE W BOOST..: Unknown if received radiation therapy			
  NUMBER OF RADIATION TREATMENTS..: Unknown if radiation given			
361  DATE RADIATION THERAPY ENDED....			
784  ENDOCAVITARY RADIATION..........			
785  INTRA-OPERATIVE RAD THERAPY.....			
786  PRIMARY TUMOR RAD DOSE W BOOST..			
787  NUMBER OF RADIATION TREATMENTS..			
  DATE CHEMOTHERAPY STARTED.......: 			
  ADJUVANT CHEMO W BEAM RADIATION.: No concomitant treatment			
  ADJUVANT THERAPY:			
  DURATION OF ADJUVANT THERAPY....: No adjuvant therapy			
  COMPLETED DURATION OF THERAPY...: No (0-1 cycle)			
  ADJUVANT CHEMO W BEAM RADIATION.: Unknown if therapy concomitant			
  DURATION OF ADJUVANT THERAPY....: Unknown if therapy given			
  COMPLETED DURATION OF THERAPY...: Unknown if therapy given			
788  ADJUVANT CHEMO W BEAM RADIATION.			
794  DURATION OF ADJUVANT THERAPY....			
795  COMPLETED DURATION OF THERAPY...			
WERE OTHER REFERRALS MADE			
TABLE V - QUALITY OF LIFE			
WERE OTHER REFERRALS MADE:			
796  NUTRITIONAL CONSULTATION			
797  OCCUPATIONAL THERAPY....			
563  PHYSICAL THERAPY........			
798  OSTOMY CONSULTATION.....			
70DATE OF FIRST RECURRENCE......			
71TYPE OF FIRST RECURRENCE......			
DATE OF LAST CONTACT OR DEATH: 			
15VITAL STATUS.................			
CANCER STATUS................: 			
81COMPLETED BY.................			
82REVIEWED BY CANCER COMMITTEE.			
10. FAMILY HISTORY OF COLORECTAL CA..: 			
11. PERSONAL HISTORY OF COLORECTAL CA: 			
12. MULTI 1997 COLON/RECTUM PRIMARIES: 			
13. PERSONAL HISTORY OF NON-COLORECTAL CANCER:			
PROSTATE.........: 			
STOMACH..........: 			
THYROID..........: 			
UTERUS...........: 			
      OVARIAN CARCINOMA: 			
OTHER............: 			
14. PREVIOUS TAH/BSO.................: 			
15. OTHER PRIOR CONDITIONS:			
PRIOR POLYPS.....: 			
POLYPS...........: 			
17. DURATION OF SIGNS/SYMPTOMS PRESENT AT INITIAL DIAGNOSIS (months):			
      BOWEL OBSTRUCTION..............: 			
      CHANGE IN BOWEL HABIT..........: 			
      EMER PRESENTATION-OBSTRUCTION..: 			
      OCCULT BLOOD ONLY IN STOOL.....: 			
      RECTAL BLEEDING (MELENA).......: 			
18. INITIAL METHODS OF DIAGNOSIS:			
      SCREENING DIGITAL RECTAL EXAM..: 			
      SCREENING PHYSICAL EXAM........: 			
19. REASON LEADING TO EVENTUAL DX....: 			
20. DIAGNOSTIC EVALUATION:			
      BARIUM ENEMA, DOUBLE CONTRAST..: 			
      BARIUM ENEMA, SINGLE CONTRAST..: 			
      BARIUM ENEMA, NOS..............: 			
      BIOPSY OF PRIMARY SITE.........: 			
      BIOPSY OF METASTATIC SITE......: 			
      CT SCAN OF CHEST...............: 			
      CT SCAN OF LIVER...............: 			
      CT SCAN OF PRIMARY SITE........: 			
      CHEST ROENTGENOGRAM............: 			
      DIGITAL RECTAL EXAM............: 			
      FLEXIBLE SIGMOIDOSCOPY.........: 			
      INTRAVENOUS PYELOGRAM..........: 			
      SERUM-LIVER FUNCTION TEST......: 			
      STOOL GUAIAC (OCCULT BLOOD)....: 			
21. LEVEL OF TUMOR BY ENDOSCOPIC EXAM: 			
22. LEVEL OF RECTAL TUMOR............: 			
23. DATE OF INITIAL DIAGNOSIS........: 			
24. PRIMARY SITE.....................: 			
25. HISTOLOGY/26. BEHAVIOR CODE......: 			
28. DIAGNOSTIC CONFIRMATION..........: 			
Print Colorectal Cancer PCE			
 PCE Study of Colorectal Cancer			
29. SIZE OF TUMOR (mm)...............: 			
30. REGIONAL NODES EXAMINED..........: 			
31. REGIONAL NODES POSITIVE..........: 			
32. AJCC CLINICAL STAGE (cTNM):			
      AJCC STAGE.....................: 			
33. AJCC PATHOLOGIC STAGE (pTNM):			
34. STAGED BY:			
      CLINICAL STAGE.................: 			
      PATHOLOGIC STAGE...............: 			
35. MARGIN OF RESECTION:			
      PROXIMAL MARGIN................: 			
      DISTAL MARGIN..................: 			
      RADIAL MARGIN..................: 			
36. DISTANCE TO MUCOSAL MARGIN.......: 			
37. DISTANCE TO RADIAL MARGIN........: 			
38. BLOOD VESSEL/LYMPHATIC INVASION..: 			
39. EXTRAMURAL VENOUS INVASION.......: 			
40. PROMINENT LYMPHOID INFILTRATE....: 			
41. PHYSICIAN PROVIDING TREATMENT....: 			
42. FIRST COURSE OF TREATMENT DATE...: 			
43. DATE OF INPATIENT ADMISSION......: 			
44. DATE OF INPATIENT DISCHARGE......: 			
45. NON CANCER-DIRECTED SURGERY DATE.: 			
46. NON CANCER-DIRECTED SURGERY......: 			
47. SURGERY OF PRIMARY SITE DATE.....: 			
48. SURGERY OF PRIMARY SITE..........: 			
49. ADDITIONAL SURGICAL PROCEDURES...: 			
50. LAPAROSCOPY USED DURING SURGERY..: 			
51. METHOD OF ANASTOMOSIS............: 			
52. DIST OF ANASTOMOSIS FROM DENTATE.: 			
53. RESIDUAL PRIMARY TUMOR...........: 			
54. OTHER SURGERY:			
      PATHOLOGICAL STATUS............: 			
55. COMPLICATIONS AFTER FIRST COURSE OF TREATMENT:			
      ABDOMINAL INFECTION......: 			
PERINEAL INFECTION.......: 			
PNEUMONIA................: 			
      ADMISSION FOR NEUTROPENIA: 			
PROCTITIS................: 			
      ANASTOMOTIC DEHISCENCE...: 			
PULMONARY EMBOLISM.......: 			
RADIATION ENTERITIS......: 			
STOMA COMPLICATION.......: 			
URINARY TRACT INFECTION..: 			
      EARLY BOWEL OBSTRUCTION..: 			
56. POSTOPERATIVE DEATH W/I 30 DAYS: 			
57. DATE RADIATION STARTED...........: 			
58. DATE RADIATION THERAPY ENDED.....: 			
59. ENDOCAVITARY RADIATION...........: 			
60. INTRA-OPERATIVE RAD THERAPY......: 			
61. PRIMARY TUMOR RAD DOSE W BOOST...: 			
62. NUMBER OF RADIATION TREATMENTS...: 			
64. DATE CHEMOTHERAPY STARTED........: 			
65. ADJUVANT CHEMO W BEAM RADIATION..: 			
66. ADJUVANT THERAPY:			
CPT 11.............: 			
TAXOL..............: 			
OTHER..............: 			
67. DURATION OF ADJUVANT THERAPY.....: 			
68. COMPLETED DURATION OF THERAPY....: 			
69. WERE OTHER REFERRALS MADE:			
      NUTRITIONAL CONSULTATION.......: 			
      OCCUPATIONAL THERAPY...........: 			
      PHYSICAL THERAPY...............: 			
      OSTOMY CONSULTATION............: 			
70. DATE OF FIRST RECURRENCE..........: 			
71. TYPE OF FIRST RECURRENCE..........: 			
72. DATE OF LAST CONTACT OR DEATH....: 			
73. VITAL STATUS.....................: 			
74. CANCER STATUS....................: 			
75. COMPLETED BY.....................: 			
76. REVIEWED BY CANCER COMMITTEE.....: 			
Deleting data from the following fields...			
 SURGICAL DX/STAGING PROC			
 SURGICAL DX/STAGING PROC DATE			
  SURGERY OF PRIMARY (R)			
  SURGICAL APPROACH (R)			
  SURGERY OF PRIMARY (F)			
  SURGERY OF PRIMARY DATE			
  SURGICAL MARGINS			
  DATE OF SURGICAL DISCHARGE			
  REASON FOR NO SURGERY			
  SURGERY OF PRIMARY SITE			
  SURGERY OF PRIMARY SITE DATE			
  SCOPE OF LN SURGERY (R)			
  NUMBER OF LN REMOVED (R)			
  SCOPE OF LN SURGERY (F)			
  SCOPE OF LYMPH NODE SURG DATE			
  SURG PROC/OTHER SITE (R)			
  SURG PROC/OTHER SITE (F)			
  SURG PROC/OTHER SITE DATE			
  DATE RADIATION STARTED			
  LOCATION OF RADIATION TX			
  RADIATION TREATMENT VOLUME			
  REGIONAL TREATMENT MODALITY			
  REGIONAL DOSE:cGy			
  BOOST TREATMENT MODALITY			
  BOOST DOSE:cGy			
  NUMBER OF TXS TO THIS VOLUME			
  RADIATION/SURGERY SEQUENCE			
  DATE RADIATION ENDED			
  REASON FOR NO RADIATION			
  TEXT-RX-RADIATION OTHER			
  CHEMOTHERAPY DATE			
  REASON FOR NO CHEMOTHERAPY			
  HORMONE THERAPY			
  HORMONE THERAPY DATE			
  REASON FOR NO HORMONE THERAPY			
  IMMUNOTHERAPY DATE			
  HEMA TRANS/ENDOCRINE PROC			
  HEMA TRANS/ENDOCRINE PROC DATE			
  OTHER TREATMENT			
  OTHER TREATMENT DATE			
  PALLIATIVE PROCEDURE @FAC			
 SURGICAL DX/STAGING @FAC			
 SURGICAL DX/STAGING @FAC DATE			
  SURGERY OF PRIMARY @FAC (R)			
  SURGERY OF PRIMARY @FAC (F)			
  SURGERY OF PRIMARY @FAC DATE			
  SCOPE OF LN SURGERY @FAC (R)			
  NUMBER OF LN REMOVED @FAC (R)			
  SCOPE OF LN SURGERY @FAC (F)			
  SCOPE OF LN SURGERY @FAC DATE			
  SURG PROC/OTHER SITE @FAC (R)			
  SURG PROC/OTHER SITE @FAC (F)			
  SURG PROC/OTHER SITE @FAC DATE			
RADIATION @FAC DATE			
  CHEMOTHERAPY @FAC DATE			
  HORMONE THERAPY @FAC			
  HORMONE THERAPY @FAC DATE			
  IMMUNOTHERAPY @FAC DATE			
  OTHER TREATMENT @FAC			
  OTHER TREATMENT @FAC DATE			
STATE AT DX = YY (			
POSTAL CODE AT DX must be 888888888			
STATE AT DX = ZZ (			
POSTAL CODE AT DX must be 999999999			
REPORTING HOSPITAL = FACILITY REFERRED FROM			
REPORTING HOSPITAL = FACILITY REFERRED TO			
CLASS OF CASE = 			
FACILITY REFERRED FROM may not be blank			
DATE OF FIRST CONTACT..: 			
 later than			
SURGERY OF PRIMARY SITE DATE.: 			
RADIATION DATE...............: 			
RADIATION THERAPY TO CNS DATE: 			
CHEMOTHERAPY DATE............: 			
HORMONE THERAPY DATE.........: 			
IMMUNOTHERAPY DATE...........: 			
OTHER TREATMENT DATE.........: 			
 earlier than			
DATE DX......................: 			
TYPE OF REPORTING SOURCE = 6 (			
CLASS OF CASE must be 5 (Dx at autopsy)			
CLASS OF CASE = 5 (			
TYPE OF REPORTING SOURCE must be 6 (Autopsy only)			
TYPE OF REPORTING SOURCE = 7 (			
DIAGNOSTIC CONFIRMATION must be 9 (Unk if microscopically confirmed)			
DIAGNOSTIC CONFIRMATION must be 1 (Pos histology) or			
                                6 (Direct visualization)			
 is a paired site			
LATERALITY must be provided for specified paired organs/sites			
NOTE: If NASAL CARTILAGE or NASAL SEPTUM, override this warning.			
NOTE: If CARINA, override this warning.			
NOTE: If STERNUM, override this warning.			
NOTE: If SACRUM, COCCYX or SYMPHYSIS PUBIS, override this warning.			
 is an unpaired site			
LATERALITY must be 0 (Not a paired site)			
BEHAVIOR CODE = 2 (In situ)			
SUMMARY STAGE = 			
BEHAVIOR CODE and SUMMARY STAGE confict			
BEHAVIOR CODE = 3 (Malignant)			
SUMMARY STAGE = 0 (In situ)			
HISTOLOGY = 			
TYPE OF REPORTING SOURCE = 			
SUMMARY STAGE must be 7 (Distant Mets/systemic disease)			
GRADE/DIFFERENTIATION must be 1 (Grade I)			
GRADE/DIFFERENTIATION must be 2 (Grade II)			
GRADE/DIFFERENTIATION must be 4 (Grade IV)			
GRADE/DIFFERENTIATION must be: 3 (Grade III)			
                               7 (Null cell)			
####################	####################	####################	
####################	####################	####################	
####################	####################	####################	
####################	####################	####################	
####################	####################	####################